Zacks Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-29,149
Closed -$139K 503
2020
Q2
$139K Buy
+29,149
New +$139K ﹤0.01% 483